Optimal Use of Adjuvant Bisphosphonates and Breast Cancer
- PMID: 28654362
- DOI: 10.1200/JCO.2017.73.6157
Optimal Use of Adjuvant Bisphosphonates and Breast Cancer
Comment in
-
Reply to T.J. Powles et al.J Clin Oncol. 2017 Aug 10;35(23):2720-2721. doi: 10.1200/JCO.2017.73.8567. Epub 2017 Jun 27. J Clin Oncol. 2017. PMID: 28654367 No abstract available.
Comment on
-
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.J Clin Oncol. 2017 Jun 20;35(18):2062-2081. doi: 10.1200/JCO.2016.70.7257. Epub 2017 Mar 6. J Clin Oncol. 2017. PMID: 28618241
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
